EVALUATION OF FOCAL LIVER LESIONS ON ULTRASOUND IN POST-TREATMENT PATIENTS OF HEPATITIS C
DOI:
https://doi.org/10.5281/zenodo.24161461Abstract
Background: Hepatitis C virus (HCV) infection is a major cause of cirrhosis and hepatocellular carcinoma. Patients may still develop focal liver lesions (FLLs) after antiviral treatment, and ultrasound is the usual first-line imaging tool for detecting them. To evaluate the ultrasound features of focal liver lesions in patients who had been treated for hepatitis C. Methods: This descriptive study was conducted at Al Razi Diagnostic Center over four months. Thirty treated HCV patients aged 18 years or older with single or multiple FLLs on ultrasound were enrolled by convenience sampling. Scanning was performed on a Toshiba Aplio ultrasound machine. Age, gender, lesion location, margins, echogenicity, echotexture and vascularity were recorded on a structured proforma and analysed in SPSS version 24 and R. Results: Mean age was 43.5 ± 16.1 years (range 20–81); 20 patients (66.7%) were male and 10 (33.3%) female. Twenty-one patients (70.0%) were aged below 50 years. Lesions were located in the right lobe (including segmental involvement) in 20 patients (66.7%), diffusely in 8 (26.7%) and in the left lobe in 2 (6.7%). Margins were irregular in 15 (50.0%). Most lesions were hypoechoic (19; 63.3%), the most frequent echotexture was coarse (13; 43.3%), and 26 lesions (86.7%) showed no vascularity on Doppler. Conclusion: In this sample, FLLs after HCV treatment were more frequent in men and in the right lobe, and were mostly hypoechoic with irregular margins and no detectable vascularity. Because these findings can overlap with malignancy, treated patients with such lesions need regular ultrasound follow-up and further characterisation where indicated.
Keywords: Focal liver lesion; hepatitis C; ultrasonography; post-treatment; echogenicity; Doppler.




